55th ASH Annual Meeting - Conference Review, reviewed by Professor Jeff Szer

In this Issue:

CALR mutations in myeloproliferative neoplasms
Genomic landscape of myeloproliferative neoplasms
Adjusted D-dimer levels to exclude PE in older patients
The mechanism of action of lenalidomide
Overall survival analysis from the COMFORT studies
Lenalidomide for newly diagnosed multiple myeloma
Outcomes for older patients undergoing NMA haploBMT
Auto or allo for APL patients in complete second remission?
G-CSF stimulated bone marrow for sibling allografts
CART cells for management of refractory malignancies

Please login below to download this issue (PDF)

Subscribe